COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data Source and Sample
2.2. Definition and Measurement of Dependent Variables
2.3. Definition and Measurement of Independent Variables
2.4. Statistical Analyses
3. Results
3.1. Characteristics of Respondents
3.2. COVID-19 Vaccination Willingness Rate
3.3. Results of Chi-Square Test
3.4. Results of Multiple Ordered Logistic Regressions
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Coronavirus Disease (COVID-2019) Situation Reports. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed on 4 February 2021).
- DRAFT Landscape of COVID-19 Candidate Vaccines—30 April 2020. Available online: https://www.who.int/whodocuments-detail/draft-landscape-of-COVID-19-candidate-vaccines (accessed on 16 March 2021).
- COVID-19 Vaccination Free to Chinese Residents: Official. Available online: http://www.ecns.cn/news/2021-01-09/detail-ihafqmaz1834647.shtml (accessed on 5 February 2021).
- Yoda, T.; Katsuyama, H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines 2021, 9, 48. [Google Scholar] [CrossRef]
- Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef] [PubMed]
- Lin, Y.; Hu, Z.; Zhao, Q.; Alias, H.; Danaee, M.; Wong, L.P. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl. Trop. Dis. 2020, 14, e0008961. [Google Scholar] [CrossRef]
- Nzaji, M.K.; Ngombe, L.K.; Mwamba, G.N.; Ndala, D.B.B.; Miema, J.M.; Lungoyo, C.L.; Mwimba, B.L.; Bene, A.C.M.; Musenga, E.M. Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo. Pragm. Observ. Res. 2020, 11, 103–109. [Google Scholar] [CrossRef]
- Graffigna, G.; Palamenghi, L.; Boccia, S.; Barello, S. Relationship between Citizens’ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis. Vaccines 2020, 8, 576. [Google Scholar] [CrossRef]
- Mohammed, A.-M.; Kumar, P.B. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J. Multidiscip. Healthc. 2020, 13, 1657–1663. [Google Scholar] [CrossRef]
- Goldman, R.D.; Yan, T.D.; Seiler, M.; Cotanda, C.P.; Brown, J.C.; Klein, E.J.; Hoeffe, J.; Gelernter, R.; Hall, J.E.; Davis, A.L.; et al. International COVID-19 Parental Attitude Study Group Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey. Vaccine 2020. [Google Scholar] [CrossRef] [PubMed]
- Verger, P.; Scronias, D.; Dauby, N.; Adedzi, K.A.; Gobert, C.; Bergeat, M.; Gagneur, A.; Dubé, E. Attitudes of healthcare workers towards COVID-19 vaccination: A survey in France and French-speaking parts of Belgium and Canada, 2020. Euro Surv. Bull. Eur. Mal. Trans. Eur. Commun. Dis. Bull. 2021, 26. [Google Scholar] [CrossRef]
- Unroe, K.T.; Evans, R.; Weaver, L.; Rusyniak, D.; Blackburn, J. Willingness of long-term care staff to receive a COVID-19 vaccine: A single state survey. J. Am. Geriat. Soc. 2020. [Google Scholar] [CrossRef]
- Bell, S.; Clarke, R.; Mounier-Jack, S.; Walker, J.L.; Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020. [Google Scholar] [CrossRef]
- Leng, A.; Maitland, E.; Wang, S.; Nicholas, S.; Liu, R.; Wang, J. Individual preferences for COVID-19 vaccination in China. Vaccine 2021, 39, 247–254. [Google Scholar] [CrossRef]
- Dong, D.; Xu, R.H.; Wong, E.L.-Y.; Hung, C.-T.; Feng, D.; Feng, Z.; Yeoh, E.-K.; Wong, S.Y.-S. Public preference for COVID-19 vaccines in China: A discrete choice experiment. Health Expect. Int. J. Public Particip. Health Care Health Policy 2020. [Google Scholar] [CrossRef]
- Borriello, A.; Master, D.; Pellegrini, A.; Rose, J.M. Preferences for a COVID-19 vaccine in Australia. Vaccine 2020, 39, 473–479. [Google Scholar] [CrossRef] [PubMed]
- García, L.Y.; Cerda, A.A. Contingent assessment of the COVID-19 vaccine. Vaccine 2020, 38, 5424–5429. [Google Scholar] [CrossRef]
- Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; Exel, J.v.; Schreyögg, J.; Stargardt, T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 2020, 21, 977–982. [Google Scholar] [CrossRef] [PubMed]
- Dodd, R.H.; Cvejic, E.; Bonner, C.; Pickles, K.; McCaffery, K.J. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 vaccine acceptance in the US. EClinMed 2020, 26, 100495. [Google Scholar] [CrossRef]
- Alqudeimat, Y.; Alenezi, D.; AlHajri, B.; Alfouzan, H.; Almokhaizeem, Z.; Altamimi, S.; Almansouri, W.; Alzalzalah, S.; Ziyab, A. Acceptance of a COVID-19 Vaccine and its Related Determinants among the General Adult Population in Kuwait. Med. Princ. Pract. Int. J. Kuwait Univ. Health Sci. Cent. 2021. [Google Scholar] [CrossRef]
- Sarasty, O.; Carpio, C.E.; Hudson, D.; Guerrero-Ochoa, P.A.; Borja, I. The demand for a COVID-19 vaccine in Ecuador. Vaccine 2020, 38, 8090–8098. [Google Scholar] [CrossRef]
- Willingness to pay for a COVID-19 vaccine high in Chile. Pharm. Econ. Outcomes News 2020, 858, 35. [CrossRef]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Vo, T.Q.; et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum. Vaccines Immunother. 2020, 16, 3074–3080. [Google Scholar] [CrossRef]
- Wong, L.P.; Alias, H.; Wong, P.F.; Lee, H.Y.; AbuBakar, S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum. Vaccines Immunother. 2020, 16, 2204–2214. [Google Scholar] [CrossRef] [PubMed]
- Guidry, J.P.D.; Laestadius, L.I.; Vraga, E.K.; Miller, C.A.; Perrin, P.B.; Burton, C.W.; Ryan, M.; Fuemmeler, B.F.; Carlyle, K.E. Willingness to get the COVID-19 Vaccine with and without Emergency Use Authorization. Am. J. Infect. Control 2020, 49, 137–142. [Google Scholar] [CrossRef] [PubMed]
- Jiang, S. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ehde, D.M.; Roberts, M.K.; Herring, T.E.; Alschuler, K.N. Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States. Mult. Scler. Relat. Disord. 2021, 49, 102788. [Google Scholar] [CrossRef] [PubMed]
- Miyachi, T.; Takita, M.; Senoo, Y.; Yamamoto, K. Lower trust in national government links to no history of vaccination. Lancet 2020, 395, 31–32. [Google Scholar] [CrossRef] [Green Version]
- Liu, Z.; Yang, J.Z. In the Wake of Scandals: How Media Use and Social Trust Influence Risk Perception and Vaccination Intention among Chinese Parents. Health Commun. 2020, 1–12. [Google Scholar] [CrossRef] [PubMed]
Variables | N | % | |
---|---|---|---|
Sex | Male | 1154 | 48.55 |
Female | 1223 | 51.45 | |
Age | 18–27 | 915 | 38.49 |
28–37 | 340 | 14.30 | |
38–47 | 460 | 19.35 | |
48–57 | 426 | 17.92 | |
58+ | 236 | 9.93 | |
Income | High (≥RMB8000) | 813 | 34.20 |
Medium (≥RMB4000–<RMB8000) | 796 | 33.49 | |
Low (<RMB4000) | 768 | 32.31 | |
Education level | Below high school | 1472 | 61.93 |
High school and above | 905 | 38.07 | |
Occupation | Professional | 708 | 29.79 |
Farmer | 278 | 11.70 | |
Migrant worker | 289 | 12.16 | |
Self-employed | 221 | 9.30 | |
Unemployed | 103 | 4.33 | |
Student | 639 | 26.88 | |
Retired | 86 | 3.62 | |
Other | 53 | 2.23 | |
Medical insurance | Yes | 2289 | 96.30 |
No | 88 | 3.70 | |
Residence | Urban | 1462 | 61.51 |
Rural | 915 | 38.49 | |
Self-rated health | Bad | 73 | 3.07 |
Medium | 564 | 23.73 | |
Good | 1740 | 73.20 | |
Region | Eastern | 748 | 31.47 |
Central | 686 | 28.86 | |
Western | 943 | 39.67 | |
Vaccine effectiveness | Low | 17 | 0.72 |
Medium | 301 | 12.66 | |
High | 2059 | 86.62 | |
Vaccine safety | Low | 40 | 1.68 |
Medium | 378 | 15.90 | |
High | 1959 | 82.41 | |
Risk of infection | Low | 1107 | 46.57 |
Medium | 670 | 28.19 | |
High | 600 | 25.24 |
Variables | VWR of Paid Vaccine | VWR of Free Vaccine | Comparison between Paid and Free Vaccination | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | % | χ2 | p | N | % | χ2 | p | χ2 | p | ||
Sex | Male | 862 | 74.70 | 1.50 | 0.471 | 953 | 82.58 | 0.72 | 0.698 | 498.37 | <0.001 |
Female | 888 | 72.61 | 1002 | 81.93 | 346.51 | <0.001 | |||||
Age | 18–27 | 670 | 73.22 | 63.75 | <0.001 | 755 | 82.51 | 25.12 | 0.001 | 244.42 | <0.001 |
28–37 | 266 | 78.24 | 291 | 85.59 | 93.89 | <0.001 | |||||
38–47 | 321 | 69.78 | 362 | 78.70 | 185.32 | <0.001 | |||||
48–57 | 329 | 77.23 | 349 | 81.92 | 208.45 | <0.001 | |||||
58+ | 164 | 69.49 | 198 | 83.90 | 66.22 | <0.001 | |||||
Income | High | 602 | 74.05 | 2.95 | 0.565 | 642 | 78.97 | 15.35 | 0.004 | 339.79 | <0.001 |
Medium | 584 | 73.37 | 651 | 81.78 | 271.24 | <0.001 | |||||
Low | 564 | 73.44 | 662 | 86.20 | 235.30 | <0.001 | |||||
Education level | Below high school | 1093 | 74.25 | 22.71 | <0.001 | 1228 | 83.42 | 7.68 | 0.021 | 536.48 | <0.001 |
High school and above | 657 | 72.60 | 727 | 80.33 | 280.16 | <0.001 | |||||
Occupation | Professional | 525 | 74.15 | 36.93 | 0.001 | 559 | 78.95 | 35.57 | 0.001 | 290.55 | <0.001 |
Farmer | 213 | 76.62 | 247 | 88.85 | 99.27 | <0.001 | |||||
Migrant worker | 220 | 76.12 | 239 | 82.70 | 104.51 | <0.001 | |||||
Self-employed | 152 | 68.78 | 180 | 81.45 | 78.91 | <0.001 | |||||
Unemployed | 71 | 68.93 | 89 | 86.41 | 29.02 | <0.001 | |||||
Student | 468 | 73.24 | 525 | 82.16 | 184.11 | <0.001 | |||||
Retired | 63 | 73.26 | 73 | 84.88 | 43.66 | <0.001 | |||||
Other | 38 | 71.70 | 43 | 81.13 | 13.47 | 0.009 | |||||
Medical insurance | Yes | 1700 | 74.27 | 13.66 | 0.001 | 1892 | 82.66 | 8.39 | 0.015 | 786.92 | <0.001 |
No | 50 | 56.82 | 63 | 71.59 | 36.37 | <0.001 | |||||
Residence | Urban | 1080 | 73.87 | 0.84 | 0.657 | 1197 | 81.87 | 0.39 | 0.821 | 582.10 | <0.001 |
Rural | 670 | 73.22 | 758 | 82.84 | 258.51 | <0.001 | |||||
Self-rated health | Bad | 50 | 68.49 | 7.79 | 0.100 | 60 | 82.19 | 1.17 | 0.883 | 11.14 | 0.025 |
Medium | 400 | 70.92 | 466 | 82.62 | 161.68 | <0.001 | |||||
Good | 1300 | 74.71 | 1429 | 82.13 | 680.67 | <0.001 | |||||
Region | Eastern | 546 | 72.99 | 6.80 | 0.147 | 603 | 80.61 | 10.40 | 0.034 | 265.17 | <0.001 |
Central | 505 | 73.62 | 573 | 83.53 | 386.46 | <0.001 | |||||
Western | 699 | 74.13 | 779 | 82.61 | 188.60 | <0.001 | |||||
Vaccine effectiveness | Low | 8 | 47.06 | 124.14 | <0.001 | 7 | 41.18 | 245.71 | <0.001 | 14.85 | 0.005 |
Medium | 147 | 48.84 | 162 | 53.82 | 138.87 | <0.001 | |||||
High | 1595 | 77.46 | 1786 | 86.74 | 529.37 | <0.001 | |||||
Vaccine safety | Low | 18 | 45.00 | 167.88 | <0.001 | 21 | 52.50 | 279.62 | <0.001 | 25.40 | <0.001 |
Medium | 194 | 51.32 | 214 | 56.61 | 199.46 | <0.001 | |||||
High | 1538 | 78.51 | 1720 | 87.80 | 421.77 | <0.001 | |||||
Risk of infection | Low | 802 | 72.45 | 9.22 | 0.056 | 914 | 82.57 | 12.69 | 0.013 | 394.98 | <0.001 |
Medium | 485 | 72.39 | 535 | 79.85 | 250.14 | <0.001 | |||||
High | 463 | 77.17 | 506 | 84.33 | 206.12 | <0.001 |
Variables | Paid Vaccine | Free Vaccine | |||||||
---|---|---|---|---|---|---|---|---|---|
β | S.E. | p | OR (95% CI) | β | S.E. | p | OR (95% CI) | ||
Sex | Male | (Reference group) | (Reference group) | ||||||
Female | −0.09 | 0.10 | 0.335 | 0.910 (0.752, 1.102) | −0.11 | 0.12 | 0.353 | 0.898 (0.715, 1.127) | |
Age | 18–27 | (Reference group) | (Reference group) | ||||||
28–37 | 0.28 | 0.19 | 0.146 | 1.325 (0.907, 1.937) | 0.15 | 0.24 | 0.521 | 1.164 (0.732, 1.849) | |
38–47 | −0.14 | 0.18 | 0.426 | 0.869 (0.614, 1.229) | −0.32 | 0.21 | 0.130 | 0.724 (0.476, 1.100) | |
48–57 | 0.07 | 0.19 | 0.706 | 1.075 (0.739, 1.562) | −0.37 | 0.23 | 0.101 | 0.691 (0.445, 1.075) | |
58+ | −0.54 | 0.23 | 0.019 | 0.581 (0.370, 0.913) | −0.79 | 0.29 | 0.006 | 0.456 (0.260, 0.799) | |
Income | High | (Reference group) | (Reference group) | ||||||
Medium | −0.06 | 0.12 | 0.645 | 0.945 (0.743, 1.202) | 0.17 | 0.14 | 0.223 | 1.187 (0.901, 1.565) | |
Low | −0.06 | 0.14 | 0.661 | 0.942 (0.723, 1.229) | 0.43 | 0.16 | 0.009 | 1.536 (1.113, 2.118) | |
Education level | Below high school | (Reference group) | (Reference group) | ||||||
High school and above | −0.16 | 0.12 | 0.197 | 0.855 (0.673, 1.085) | −0.21 | 0.14 | 0.146 | 0.814 (0.617, 1.074) | |
Occupation | Professional | (Reference group) | (Reference group) | ||||||
Farmer | 0.22 | 0.21 | 0.283 | 1.247 (0.833, 1.865) | 0.70 | 0.26 | 0.008 | 2.016 (1.205, 3.373) | |
Migrant worker | 0.08 | 0.18 | 0.649 | 1.086 (0.761, 1.550) | 0.10 | 0.21 | 0.616 | 1.111 (0.737, 1.673) | |
Self-employed | −0.36 | 0.18 | 0.046 | 0.695 (0.486, 0.993) | 0.03 | 0.22 | 0.887 | 1.032 (0.672, 1.584) | |
Unemployed | −0.07 | 0.26 | 0.793 | 0.933 (0.556, 1.566) | 0.62 | 0.35 | 0.077 | 1.859 (0.936, 3.693) | |
Student | −0.04 | 0.18 | 0.800 | 0.956 (0.676, 1.353) | −0.11 | 0.21 | 0.610 | 0.897 (0.591, 1.361) | |
Retired | 0.13 | 0.29 | 0.663 | 1.137 (0.638, 2.024) | 0.58 | 0.37 | 0.111 | 1.789 (0.875, 3.659) | |
Other | −0.16 | 0.33 | 0.637 | 0.854 (0.445, 1.641) | 0.05 | 0.40 | 0.901 | 1.050 (0.483, 2.284) | |
Medical insurance | Yes | (Reference group) | (Reference group) | ||||||
No | −0.70 | 0.22 | 0.002 | 0.496 (0.321, 0.766) | −0.67 | 0.26 | 0.011 | 0.513 (0.306, 0.858) | |
Residence | Urban | (Reference group) | (Reference group) | ||||||
Rural | −0.05 | 0.11 | 0.666 | 0.955 (0.773, 1.178) | −0.09 | 0.13 | 0.477 | 0.913 (0.711, 1.173) | |
Self-rated health | Bad | (Reference group) | (Reference group) | ||||||
Medium | 0.23 | 0.28 | 0.413 | 1.262 (0.723, 2.204) | 0.34 | 0.36 | 0.333 | 1.411 (0.703, 2.834) | |
Good | 0.34 | 0.28 | 0.230 | 1.399 (0.808, 2.422) | 0.27 | 0.35 | 0.443 | 1.306 (0.660, 2.584) | |
Region | Eastern | (Reference group) | (Reference group) | ||||||
Central | 0.03 | 0.13 | 0.823 | 1.029 (0.800, 1.325) | 0.08 | 0.15 | 0.593 | 1.085 (0.804, 1.464) | |
Western | 0.08 | 0.12 | 0.485 | 1.088 (0.859, 1.378) | −0.03 | 0.14 | 0.850 | 0.974 (0.738, 1.284) | |
Vaccine effectiveness | Low | (Reference group) | (Reference group) | ||||||
Medium | −0.05 | 0.52 | 0.920 | 0.950 (0.344, 2.622) | 0.80 | 0.54 | 0.138 | 2.229 (0.773, 6.430) | |
High | 0.66 | 0.52 | 0.202 | 1.931 (0.703, 5.303) | 1.70 | 0.54 | 0.002 | 5.490 (1.910, 15.785) | |
Vaccine safety | Low | (Reference group) | (Reference group) | ||||||
Medium | 0.72 | 0.35 | 0.037 | 2.061 (1.044, 4.068) | 0.73 | 0.36 | 0.046 | 2.071 (1.013, 4.234) | |
High | 1.55 | 0.34 | <0.001 | 4.692 (2.411, 9.131) | 1.89 | 0.36 | <0.001 | 6.641 (3.279, 13.450) | |
Risk of infection | Low | (Reference group) | (Reference group) | ||||||
Medium | 0.17 | 0.11 | 0.146 | 1.181 (0.944, 1.478) | 0.06 | 0.14 | 0.657 | 1.062 (0.814, 1.386) | |
High | 0.20 | 0.12 | 0.101 | 1.221 (0.962, 1.550) | 0.03 | 0.15 | 0.819 | 1.034 (0.778, 1.374) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Liu, R.; Zhang, Y.; Nicholas, S.; Leng, A.; Maitland, E.; Wang, J. COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy. Vaccines 2021, 9, 292. https://doi.org/10.3390/vaccines9030292
Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy. Vaccines. 2021; 9(3):292. https://doi.org/10.3390/vaccines9030292
Chicago/Turabian StyleLiu, Rugang, Yuxun Zhang, Stephen Nicholas, Anli Leng, Elizabeth Maitland, and Jian Wang. 2021. "COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy" Vaccines 9, no. 3: 292. https://doi.org/10.3390/vaccines9030292
APA StyleLiu, R., Zhang, Y., Nicholas, S., Leng, A., Maitland, E., & Wang, J. (2021). COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy. Vaccines, 9(3), 292. https://doi.org/10.3390/vaccines9030292